Outgoing CEO: Perrigo Outfitted To Sail On OTC, Rx And Euro Growth
Executive Summary
Hendrickson recounts Perrigo's strategies to right the ship after a hole in earnings opened from investing in a European consumer health business and operating API and dietary supplement divisions and as pricing pressures on generic drugs took some wind out of its revenue sails.
You may also be interested in...
Amazon OTCs Likely A Worry For Retailers, A Remedy For Perrigo
Amazon introduced Basic Care line of cough, cold, allergy and digestive treatment OTCs developed in a partnership with Perrigo. The range could be a major threat to store brand and private label OTCs, though success may depend on whether consumers wait for Amazon deliveries or shop at stores.